# A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant

> **NCT07572929** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 450 (estimated)

## Conditions studied

- Myeloid Disorders
- Myelodysplastic Syndromes
- Myeloproliferative Neoplasm
- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Maintenance Therapy
- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT07572929
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2034-02-01
- **Final completion:** 2034-02-01
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07572929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07572929, "A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT07572929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*